Neuralink, the neurotechnology company co-founded by Tesla ( NASDAQ: TSLA) CEO Elon Musk, has joined a clinical trial aimed ...

Conagra's Q4 results and '26 guidance disappointed, yet valuation offers optimism. Explore potential growth via asset sales ...

Bank of America’s preferreds offer strong income security and attractive yields, with low redemption risk and solid coverage.

Three patient deaths linked to gene therapies developed by Sarepta Therapeutics (SRPT) have drawn FDA scrutiny on the viral ...

Intel's restructuring focuses on AI and data centers, tempering CapEx to boost cash flow. Read here to know why we are ...

Cal-Maine Foods thrives with zero debt and diversification efforts. Discover its long-term potential despite egg price ...

Civeo remains a 'strong buy' despite its financial weakness, as shares trade at attractive valuations and the company is ...

In two years, BrightSpire Capital (BRSP) will be growing its dividend and seeing strong performance. Read the full analysis ...

The decline echoes a similar pattern in Q2 2022, which saw the Tech Demand Indicator score drop 12% following the first in a ...

Venu Holding faces worsening losses and a complex capital structure that clouds shareholder value despite growth plans. Learn ...

Solesence shows strong growth and profitability with solid management alignment, but valuation reflects aggressive ...

Citi's strategy overhaul under Jane Fraser focuses on capital efficiency, buybacks, and value growth. Click to read more on ...